Artificial intelligence is no longer a futuristic promise in the field of healthcare. In 2026, it has become a concrete tool, used every day by thousands of doctors around the world to detect diseases earlier, reduce diagnostic errors, and improve the quality of care. This silent revolution is profoundly redefining our relationship with...

What if a simple blood draw could detect more than 50 types of cancer, often before the first symptoms even appear? That is the promise of the Galleri test, developed by the American company GRAIL. A technology that could radically transform the way we approach cancer screening — provided the clinical evidence follows. How does the Galleri...